Kolodny is new CMO at Phoenix House
Andrew Kolodny, M.D., began as the Chief Medical Officer at Phoenix House on Sept. 9
Phoenix House is a nonprofit provider of substance abuse services, with 150 locations in California, Maine, New Hampshire, Virginia/Maryland/D.C., Florida, Massachusetts, Rhode Island, Vermont, New York and Texas. He was previously the chairman of the department of psychiatry at Maimonides Medical Center in Brooklyn, New York.
“Dr. Andrew Kolodny brings to Phoenix House a wealth of clinical experience in addiction medicine,” says Howard Meitiner, President and CEO of Phoenix House. “He will also contribute a passion for public education and policy reform as it relates to prescription drug abuse, which now accounts for more overdose deaths than heroin and cocaine combined."
Kolodny completed a public psychology fellowship at Columbia University and was a fellow on Congressional Health Policy. He also served as medical director of special projects in the Office of the Executive Deputy Commissioner for New York City Health and Mental Hygiene, where he developed and implemented naloxone overdose prevention programs, as well as emergency intervention and referral to treatment programs for drug and alcohol misuse.
He is a founder and the current president of Physicians for Responsible Opioid Prescribing (PROP), a 1,000-member organization that seeks to promote cautious and safe prescribing practices.
Kolodny earned his bachelor's degree from Queens College and his medical degree from Temple University School of Medicine. He completed his residency in psychiatry at Mount Sinai School of Medicine. He lives in Brooklyn.